Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 100

    1.

    Diabetes susceptibility in the Canadian Oji-Cree population is moderated by abnormal mRNA processing of HNF1A G319S transcripts.

    Harries LW, Sloman MJ, Sellers EA, Hattersley AT, Ellard S.

    Diabetes. 2008 Jul;57(7):1978-82.PMID: 18586913 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    DIABETES SUSCEPTIBILITY IN THE CANADIAN OJI-CREE POPULATION IS MODERATED BY ABNORMAL mRNA PROCESSING OF HNF1A G319S TRANSCRIPTS.

    Harries LW, Sloman MJ, Sellers EA, Hattersley AT, Ellard S.

    Diabetes. 2008 Apr 14. [Epub ahead of print]PMID: 18411242 [PubMed - as supplied by publisher]Related articles

    3.

    The private hepatocyte nuclear factor-1alpha G319S variant is associated with plasma lipoprotein variation in Canadian Oji-Cree.

    Hegele RA, Cao H, Harris SB, Hanley AJ, Zinman B, Connelly PW.

    Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):217-22.PMID: 10634821 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    The hepatic nuclear factor-1alpha G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree.

    Hegele RA, Cao H, Harris SB, Hanley AJ, Zinman B.

    J Clin Endocrinol Metab. 1999 Mar;84(3):1077-82.PMID: 10084598 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Genes, environment and Oji-Cree type 2 diabetes.

    Hegele RA, Zinman B, Hanley AJ, Harris SB, Barrett PH, Cao H.

    Clin Biochem. 2003 May;36(3):163-70. Review.PMID: 12726923 [PubMed - indexed for MEDLINE]Related articles

    6.

    Clinical utility of HNF1A genotyping for diabetes in aboriginal Canadians.

    Hegele RA, Cao H, Hanley AJ, Zinman B, Harris SB, Anderson CM.

    Diabetes Care. 2000 Jun;23(6):775-8.PMID: 10840995 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Clinical and genetic associations with hypertriglyceridemic waist in a Canadian aboriginal population.

    Pollex RL, Hanley AJ, Zinman B, Harris SB, Hegele RA.

    Int J Obes (Lond). 2006 Mar;30(3):484-91.PMID: 16276364 [PubMed - indexed for MEDLINE]Related articles

    8.

    Peroxisome proliferator-activated receptor-gamma2 P12A and type 2 diabetes in Canadian Oji-Cree.

    Hegele RA, Cao H, Harris SB, Zinman B, Hanley AJ, Anderson CM.

    J Clin Endocrinol Metab. 2000 May;85(5):2014-9.PMID: 10843190 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Synergism between mutant HNF1A and the metabolic syndrome in Oji-Cree Type 2 diabetes.

    Pollex RL, Hanley AJ, Zinman B, Harris SB, Khan HM, Hegele RA.

    Diabet Med. 2005 Nov;22(11):1510-5.PMID: 16241915 [PubMed - indexed for MEDLINE]Related articles

    10.

    HNF-1alpha G319S, a transactivation-deficient mutant, is associated with altered dynamics of diabetes onset in an Oji-Cree community.

    Triggs-Raine BL, Kirkpatrick RD, Kelly SL, Norquay LD, Cattini PA, Yamagata K, Hanley AJ, Zinman B, Harris SB, Barrett PH, Hegele RA.

    Proc Natl Acad Sci U S A. 2002 Apr 2;99(7):4614-9. Epub 2002 Mar 19.PMID: 11904371 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young.

    Bulman MP, Harries LW, Hansen T, Shepherd M, Kelly WF, Hattersley AT, Ellard S.

    Diabetologia. 2002 Oct;45(10):1463-7. Epub 2002 Sep 11.PMID: 12378390 [PubMed - indexed for MEDLINE]Related articles

    13.

    Gender, obesity, hepatic nuclear factor-1alpha G319S and the age-of-onset of type 2 diabetes in Canadian Oji-Cree.

    Hegele RA, Cao H, Harris SB, Zinman B, Hanley AJ, Anderson CM.

    Int J Obes Relat Metab Disord. 2000 Aug;24(8):1062-4.PMID: 10951547 [PubMed - indexed for MEDLINE]Related articles

    14.

    Disparity between association and linkage analysis for HNF1A G319S in type 2 diabetes in Canadian Oji-Cree.

    Hegele RA, Hanley AJ, Zinman B, Harris SB, Anderson CM.

    J Hum Genet. 2000;45(3):184-7.PMID: 10807546 [PubMed - indexed for MEDLINE]Related articles

    15.

    Isomers of the TCF1 gene encoding hepatocyte nuclear factor-1 alpha show differential expression in the pancreas and define the relationship between mutation position and clinical phenotype in monogenic diabetes.

    Harries LW, Ellard S, Stride A, Morgan NG, Hattersley AT.

    Hum Mol Genet. 2006 Jul 15;15(14):2216-24. Epub 2006 Jun 7.PMID: 16760222 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The prevalence of the HNF-1alpha G319S mutation in Canadian aboriginal youth with type 2 diabetes.

    Sellers EA, Triggs-Raine B, Rockman-Greenberg C, Dean HJ.

    Diabetes Care. 2002 Dec;25(12):2202-6.PMID: 12453961 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    [HNF-1alpha G319S mutation in Oji-Cree type 2 diabetes]

    Yamagata K.

    Nippon Rinsho. 2005 Feb;63 Suppl 2:171-5. Review. Japanese. No abstract available. PMID: 15779364 [PubMed - indexed for MEDLINE]Related articles

    18.

    Genes and environment in type 2 diabetes and atherosclerosis in aboriginal Canadians.

    Hegele RA.

    Curr Atheroscler Rep. 2001 May;3(3):216-21. Review.PMID: 11286643 [PubMed - indexed for MEDLINE]Related articles

    19.

    Hepatocyte nuclear factor-1 alpha G319S. A private mutation in Oji-Cree associated with type 2 diabetes.

    Hegele RA, Cao H, Harris SB, Hanley AJ, Zinman B.

    Diabetes Care. 1999 Mar;22(3):524. No abstract available. PMID: 10097940 [PubMed - indexed for MEDLINE]Related articles